{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:42:48Z","timestamp":1787240568017,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","award":["RGS\\R1\\221169"],"award-info":[{"award-number":["RGS\\R1\\221169"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000862","name":"Sir Halley Stewart Trust","doi-asserted-by":"publisher","award":["2728"],"award-info":[{"award-number":["2728"]}],"id":[{"id":"10.13039\/501100000862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejpb.2023.09.004","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T18:58:27Z","timestamp":1693853907000},"page":"166-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Transdermal delivery of mitochondrial-targeted hydrogen sulphide donor, AP39 protects against 6-hydroxydopamine-induced mitochondrial dysfunction"],"prefix":"10.1016","volume":"191","author":[{"given":"Mandeep Kaur","family":"Marwah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Manhoosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0973-0558","authenticated-orcid":false,"given":"Hala","family":"Shokr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Anas","family":"Al Tahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0220-0095","authenticated-orcid":false,"given":"Mohammed","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena Diaz","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sewa","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakil","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6239-6344","authenticated-orcid":false,"given":"Keqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan Singh","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4663-5752","authenticated-orcid":false,"given":"Lissette","family":"Sanchez-Aranguren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejpb.2023.09.004_b0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbadis.2009.08.013","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"1802","author":"Winklhofer","year":"2010","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Mol. Basis Dis."},{"issue":"5","key":"10.1016\/j.ejpb.2023.09.004_b0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11910-018-0829-3","article-title":"Mitochondrial dysfunction in parkinson\u2019s disease: new mechanistic insights and therapeutic perspectives","volume":"18","author":"Park","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"1","key":"10.1016\/j.ejpb.2023.09.004_b0015","first-page":"57","volume":"28","author":"Moore","year":"2005","journal-title":"Mol. Pathophysiol. Parkinson's Dis."},{"issue":"10","key":"10.1016\/j.ejpb.2023.09.004_b0020","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1021\/cn500185g","article-title":"Hydrogen sulfide: a neuromodulator and neuroprotectant in the central nervous system","volume":"5","author":"Zhang","year":"2014","journal-title":"ACS Chem. Nerosci."},{"issue":"10","key":"10.1016\/j.ejpb.2023.09.004_b0025","first-page":"1165","volume":"18","author":"Kimura","year":"2004","journal-title":"Hydrogen sulfide protects neurons from oxidative stress"},{"issue":"8","key":"10.1016\/j.ejpb.2023.09.004_b0030","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1096\/fj.06-7407com","article-title":"Sulfide, the first inorganic substrate for human cells","volume":"21","author":"Goubern","year":"2007","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.ejpb.2023.09.004_b0035","first-page":"601","volume":"27","author":"M\u00f3dis","year":"2013","journal-title":"Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics"},{"key":"10.1016\/j.ejpb.2023.09.004_b0040","doi-asserted-by":"crossref","first-page":"100024","DOI":"10.1016\/j.arres.2021.100024","article-title":"Neuroprotective effects of mitochondrial-targeted hydrogen sulphide donor, AP39 on H2O2-induced oxidative stress in human neuroblastoma SHSY5Y cell line","volume":"3","author":"Sanchez-Aranguren","year":"2021","journal-title":"Adv. Redox Res."},{"issue":"2","key":"10.1016\/j.ejpb.2023.09.004_b0045","first-page":"135","volume":"9","author":"Hu","year":"2010","journal-title":"Neuroprotective effects of hydrogen sulfide on Parkinson\u2019s disease rat models"},{"issue":"1","key":"10.1016\/j.ejpb.2023.09.004_b0050","first-page":"27","volume":"75","author":"Hu","year":"2009","journal-title":"Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function"},{"key":"10.1016\/j.ejpb.2023.09.004_b0055","doi-asserted-by":"crossref","unstructured":"C.X. Tiong, M. Lu, Bian JSJBjop, Protective effect of hydrogen sulphide against 6\u2010OHDA\u2010induced cell injury in SH\u2010SY5Y cells involves PKC\/PI3K\/Akt pathway 161(2) (2010) 467\u2013480.","DOI":"10.1111\/j.1476-5381.2010.00887.x"},{"issue":"10","key":"10.1016\/j.ejpb.2023.09.004_b0060","first-page":"876","volume":"5","author":"Zhang","year":"2014","journal-title":"Hydrogen sulfide: a neuromodulator and neuroprotectant in the central nervous system"},{"key":"10.1016\/j.ejpb.2023.09.004_b0065","first-page":"120","volume":"41","author":"Szczesny","year":"2014","journal-title":"AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro"},{"key":"10.1016\/j.ejpb.2023.09.004_b0070","first-page":"186","volume":"113","author":"Ger\u0151","year":"2016","journal-title":"The novel mitochondria-targeted hydrogen sulfide (H2S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro"},{"issue":"15","key":"10.1016\/j.ejpb.2023.09.004_b0075","doi-asserted-by":"crossref","first-page":"7816","DOI":"10.3390\/ijms22157816","article-title":"The slow-releasing and mitochondria-targeted hydrogen sulfide (H(2)S) delivery molecule AP39 induces brain tolerance to ischemia","volume":"22","author":"Pomierny","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.ejpb.2023.09.004_b0080","doi-asserted-by":"crossref","first-page":"8360738","DOI":"10.1155\/2016\/8360738","article-title":"AP39, a mitochondria-targeted hydrogen sulfide donor, supports cellular bioenergetics and protects against Alzheimer\u2019s disease by preserving mitochondrial function in APP\/PS1 mice and neurons","volume":"2016","author":"Zhao","year":"2016","journal-title":"Oxid. Med. Cell. Longevity"},{"issue":"2","key":"10.1016\/j.ejpb.2023.09.004_b0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11095-021-03164-z","article-title":"Transdermal delivery of a hydrogen sulphide donor, ADT-OH using aqueous gel formulations for the treatment of impaired vascular function: an ex vivo study","volume":"39","author":"Marwah","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2023.09.004_b0090","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.addr.2012.09.032","article-title":"Penetration enhancers","volume":"64","author":"Williams","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.ejpb.2023.09.004_b0095","doi-asserted-by":"crossref","first-page":"e11502","DOI":"10.5812\/ircmj.11502","article-title":"Transdermal fentanyl patches versus patient-controlled intravenous morphine analgesia for postoperative pain management","volume":"16","author":"Ebrahimzadeh","year":"2014","journal-title":"Iran. Red. Crescent Med. J."},{"issue":"24","key":"10.1016\/j.ejpb.2023.09.004_b0100","first-page":"3468","volume":"12","author":"Galosi","year":"2022","journal-title":"Comparison of the transdermal and intravenous administration of buprenorphine in the management of intra- and postoperative pain in dogs undergoing a unilateral mastectomy"},{"issue":"1","key":"10.1016\/j.ejpb.2023.09.004_b0105","first-page":"C81","volume":"303","author":"Xie","year":"2012","journal-title":"Hydrogen sulfide protects SH-SY5Y cells against 6-hydroxydopamine-induced endoplasmic reticulum stress"},{"issue":"2","key":"10.1016\/j.ejpb.2023.09.004_b0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/08982104.2021.1956529","article-title":"Development of a novel polymer-based carrier for deformable liposomes for the controlled dermal delivery of naringenin","volume":"32","author":"Marwah","year":"2022","journal-title":"J. Liposome Res."},{"issue":"12","key":"10.1016\/j.ejpb.2023.09.004_b0115","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1042\/CS20150351","article-title":"LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention","volume":"129","author":"Dias","year":"2015","journal-title":"Clin. Sci. (London, England: 1979)"},{"issue":"1","key":"10.1016\/j.ejpb.2023.09.004_b0120","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1038\/s41598-020-60689-w","article-title":"A dynamic perfusion based blood-brain barrier model for cytotoxicity testing and drug permeation","volume":"10","author":"Elbakary","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejpb.2023.09.004_b0125","doi-asserted-by":"crossref","first-page":"15810","DOI":"10.1038\/s41598-020-72371-2","article-title":"Bioenergetic effects of hydrogen sulfide suppress soluble Flt-1 and soluble endoglin in cystathionine gamma-lyase compromised endothelial cells","volume":"10","author":"Sanchez-Aranguren","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2023.09.004_b0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.addr.2017.12.017","article-title":"Ophthalmic gels: past, present and future","volume":"126","author":"Al-Kinani","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3\u20134","key":"10.1016\/j.ejpb.2023.09.004_b0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-hydroxydopamine model of Parkinson's disease","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotox. Res."},{"issue":"3","key":"10.1016\/j.ejpb.2023.09.004_b0140","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.taap.2011.07.021","article-title":"Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKC\u03b4 in cell culture and animal models of Parkinson's disease","volume":"256","author":"Latchoumycandane","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"10","key":"10.1016\/j.ejpb.2023.09.004_b0145","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1007\/s11064-012-0838-6","article-title":"Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase","volume":"37","author":"Iglesias-Gonz\u00e1lez","year":"2012","journal-title":"Neurochem. Res."},{"issue":"5","key":"10.1016\/j.ejpb.2023.09.004_b0150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00403-019-02017-5","article-title":"Effect of propylene glycol on the skin penetration of drugs","volume":"312","author":"Carrer","year":"2020","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.ejpb.2023.09.004_b0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0168-3659(85)90037-9","article-title":"Dermal drug delivery \u2014 improvement by choice of vehicle or drug derivative","volume":"2","author":"Hoelgaard","year":"1985","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.ejpb.2023.09.004_b0160","first-page":"1180","volume":"60","author":"Ostrenga","year":"1971","journal-title":"Significance of vehicle composition II: prediction of optimal vehicle composition"},{"issue":"1","key":"10.1016\/j.ejpb.2023.09.004_b0165","first-page":"47","volume":"52","author":"Bouwstra","year":"1989","journal-title":"Effect of N-alkyl-azocycloheptan-2-ones including azone on the thermal behaviour of human stratum corneum"},{"issue":"1","key":"10.1016\/j.ejpb.2023.09.004_b0170","first-page":"50","volume":"154","author":"Zhang","year":"2011","journal-title":"Maximum transepidermal flux for similar size phenolic compounds is enhanced by solvent uptake into the skin"},{"key":"10.1016\/j.ejpb.2023.09.004_b0175","doi-asserted-by":"crossref","first-page":"102874","DOI":"10.1016\/j.jddst.2021.102874","article-title":"Effect of glycols permeation enhancer on the release and permeation of meloxicam-natural rubber film through pig skin","volume":"66","author":"Suksaeree","year":"2021","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"7","key":"10.1016\/j.ejpb.2023.09.004_b0180","first-page":"1192","volume":"21","author":"Islam","year":"2004","journal-title":"Rheological characterization of topical carbomer gels neutralized to different pH"},{"issue":"1","key":"10.1016\/j.ejpb.2023.09.004_b0185","first-page":"180","volume":"125","author":"Hurler","year":"2012","journal-title":"Improved texture analysis for hydrogel characterization: gel cohesiveness, adhesiveness, and hardness"},{"key":"10.1016\/j.ejpb.2023.09.004_b0190","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.carbpol.2016.06.096","article-title":"Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel","volume":"153","author":"Al-Kassas","year":"2016","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.ejpb.2023.09.004_b0195","first-page":"180","volume":"125","author":"Hurler","year":"2012","journal-title":"Improved texture analysis for hydrogel characterization: Gel cohesiveness, adhesiveness, and hardness"},{"issue":"7","key":"10.1016\/j.ejpb.2023.09.004_b0200","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3109\/03639045.2012.702350","article-title":"Development of a HPMC-based controlled release formulation with hot melt extrusion (HME)","volume":"39","author":"Ma","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2023.09.004_b0205","first-page":"513","volume":"56","author":"Yilmazer","year":"1991","journal-title":"Effect of propylene glycol alginate and xanthan gum on stability of O\/W emulsions"},{"key":"10.1016\/j.ejpb.2023.09.004_b0210","unstructured":"T.J.J.S.C.C. Higuchi, Physical chemical analysis of percutaneous absorption process from creams and ointments 11 (1960) 85\u201397."},{"issue":"1","key":"10.1016\/j.ejpb.2023.09.004_b0215","first-page":"85","article-title":"Mode of action of penetration enhancers in human skin","volume":"6","author":"Barry","year":"1987","journal-title":"Mode of action of penetration enhancers in human skin"},{"issue":"10","key":"10.1016\/j.ejpb.2023.09.004_b0220","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3109\/03639041003695105","article-title":"The effect of permeation enhancers on the viscosity and the release profile of transdermal hydroxypropyl methylcellulose gel formulations containing diltiazem HCl","volume":"36","author":"Karakatsani","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2023.09.004_b0225","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1461-5347(00)00258-3","article-title":"Brain drug delivery technologies: novel approaches for transporting therapeutics","volume":"3","author":"Temsamani","year":"2000","journal-title":"Pharm. Sci. Technol. Today"},{"key":"10.1016\/j.ejpb.2023.09.004_b0230","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.niox.2015.05.001","article-title":"Mitochondria-targeted hydrogen sulfide donor AP39 improves neurological outcomes after cardiac arrest in mice","volume":"49","author":"Ikeda","year":"2015","journal-title":"Nitric Oxide"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123002370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123002370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:53:25Z","timestamp":1760547205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641123002370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":46,"alternative-id":["S0939641123002370"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.09.004","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transdermal delivery of mitochondrial-targeted hydrogen sulphide donor, AP39 protects against 6-hydroxydopamine-induced mitochondrial dysfunction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}